详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Tumor Mutation Score Is More Powerful Than Tumor Mutation Burden in Predicting Response to Immunotherapy in Non-Small Cell Lung Cancer

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE

作者：

单位： [1]Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan, Hubei, Peoples R China [2]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan, Hubei, Peoples R China

出处：

DOI：

ISSN：

关键词： Tumor Mutation Score Tumor Mutation Burden PD-L1

语种：

WOS：

中科院(CAS)分区：

出版当年[2018]版：

大类 | 1 区

医学

小类 | 2 区肿瘤学 2 区呼吸系统

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学 1 区呼吸系统

JCR分区：

出版当年[2017]版：

Q1 RESPIRATORY SYSTEM Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 21.1 最新[2023版] 16.5 最新五年平均 10.34 出版当年[2017版] 7.296 出版当年五年平均 6.595 出版前一年[2016版] 12.46 出版后一年[2018版]

第一作者：

第一作者单位： [1]Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan, Hubei, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Tumor Mutation Score Is More Powerful Than Tumor Mutation Burden in Predicting Response to Immunotherapy in Non-Small Cell Lung Cancer [2]Tumor mutation score is more powerful than tumor mutation burden in predicting response to immunotherapy in non-small cell lung cancer [3]Novel tumor mutation score versus tumor mutation burden in predicting survival after immunotherapy in pan-cancer patients from the MSK-IMPACT cohort [4]The clinical prognostic value of PD-L1 after concurrent chemoradiotherapy in Chinese nasopharyngeal carcinoma patients [5]Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach Adenocarcinoma [6]PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillance [7]PD-L1在口腔鳞状细胞癌及癌旁中表达情况的研究 [8]Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer [9]Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors [10]Identification of BAP1 mutation as a common mutation correlated with tumor mutation burden and immune infiltration in kidney renal clear cell carcinoma